Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project
van Gils, M P M Q ; Stenman, U H ; Schalken, J A ; Schroder, F H ; Luider, T M ; Lilja, Hans LU
; Bjartell, Anders
LU
; Hamdy, F C
; Pettersson, K S I
and Bischoff, R
, et al.
(2005)
In European Urology
48(6).
p.1031-1041
- Abstract
- An overview is given of serum and urine prostate cancer markers that are currently under investigation and subsequently the P-Mark project is introduced. There are many markers showing promise to overcome the limitations of prostate specific antigen (PSA). Eventually, these markers should be able to increase the specificity in diagnosis, differentiate between harmless and aggressive disease and identify progression towards androgen independence at an early stage. In the P-Mark project, several recently developed, promising markers will be evaluated using clinically well-defined biorepositories. Following successful evaluation, these markers will be validated on a sample set derived from two large, European, prostate cancer studies and used... (More)
- An overview is given of serum and urine prostate cancer markers that are currently under investigation and subsequently the P-Mark project is introduced. There are many markers showing promise to overcome the limitations of prostate specific antigen (PSA). Eventually, these markers should be able to increase the specificity in diagnosis, differentiate between harmless and aggressive disease and identify progression towards androgen independence at an early stage. In the P-Mark project, several recently developed, promising markers will be evaluated using clinically well-defined biorepositories. Following successful evaluation, these markers will be validated on a sample set derived from two large, European, prostate cancer studies and used for the identification of special risk groups in the general population. In addition, novel markers will be identified in the same biorepositories by different mass spectrometry techniques. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1133152
- author
- van Gils, M P M Q
; Stenman, U H
; Schalken, J A
; Schroder, F H
; Luider, T M
; Lilja, Hans
LU
; Bjartell, Anders
LU
; Hamdy, F C
; Pettersson, K S I
and Bischoff, R
, et al. (More)
- van Gils, M P M Q
; Stenman, U H
; Schalken, J A
; Schroder, F H
; Luider, T M
; Lilja, Hans
LU
; Bjartell, Anders
LU
; Hamdy, F C
; Pettersson, K S I
; Bischoff, R
; Takalo, H
; Nilsson, O
; Mulders, P F A
and Bangma, C H
(Less)
- organization
- publishing date
- 2005
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Prostatic neoplasms, Tumor markers, Biological, Serum, Urine, Diagnosis, Prognosis
- in
- European Urology
- volume
- 48
- issue
- 6
- pages
- 1031 - 1041
- publisher
- Elsevier
- external identifiers
-
- pmid:16054748
- scopus:27844585571
- ISSN
- 1873-7560
- DOI
- 10.1016/j.eururo.2005.06.009
- language
- English
- LU publication?
- yes
- id
- 57daa0ee-ed1e-450e-87ed-49c40c580e92 (old id 1133152)
- date added to LUP
- 2016-04-01 16:58:06
- date last changed
- 2022-01-28 23:22:58
@article{57daa0ee-ed1e-450e-87ed-49c40c580e92,
abstract = {{An overview is given of serum and urine prostate cancer markers that are currently under investigation and subsequently the P-Mark project is introduced. There are many markers showing promise to overcome the limitations of prostate specific antigen (PSA). Eventually, these markers should be able to increase the specificity in diagnosis, differentiate between harmless and aggressive disease and identify progression towards androgen independence at an early stage. In the P-Mark project, several recently developed, promising markers will be evaluated using clinically well-defined biorepositories. Following successful evaluation, these markers will be validated on a sample set derived from two large, European, prostate cancer studies and used for the identification of special risk groups in the general population. In addition, novel markers will be identified in the same biorepositories by different mass spectrometry techniques.}},
author = {{van Gils, M P M Q and Stenman, U H and Schalken, J A and Schroder, F H and Luider, T M and Lilja, Hans and Bjartell, Anders and Hamdy, F C and Pettersson, K S I and Bischoff, R and Takalo, H and Nilsson, O and Mulders, P F A and Bangma, C H}},
issn = {{1873-7560}},
keywords = {{Prostatic neoplasms; Tumor markers; Biological; Serum; Urine; Diagnosis; Prognosis}},
language = {{eng}},
number = {{6}},
pages = {{1031--1041}},
publisher = {{Elsevier}},
series = {{European Urology}},
title = {{Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project}},
url = {{http://dx.doi.org/10.1016/j.eururo.2005.06.009}},
doi = {{10.1016/j.eururo.2005.06.009}},
volume = {{48}},
year = {{2005}},
}